|
Volumn 8, Issue 2, 2007, Pages 97-98
|
Guest Editorial. Childhood tuberculosis: new recognition of an old disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIRETROVIRUS AGENT;
BCG VACCINE;
ISONIAZID;
PROTEINASE INHIBITOR;
RIFAMPICIN;
TUBERCULOSTATIC AGENT;
AIRWAY OBSTRUCTION;
BACTERIUM CULTURE;
BCG VACCINATION;
CHILDHOOD DISEASE;
DEVELOPING COUNTRY;
DIAGNOSTIC ACCURACY;
DISEASE SEVERITY;
DRUG BLOOD LEVEL;
DRUG COMPETITION;
EDITORIAL;
EPIDEMIC;
HIGH RISK PATIENT;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME;
IMMUNOCOMPROMISED PATIENT;
INCIDENCE;
INFECTION PREVENTION;
LUNG TUBERCULOSIS;
MILIARY TUBERCULOSIS;
MULTIDRUG RESISTANCE;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
SPUTUM CYTODIAGNOSIS;
THERAPY RESISTANCE;
THORAX RADIOGRAPHY;
TUBERCULIN TEST;
TUBERCULOSIS CONTROL;
UNSPECIFIED SIDE EFFECT;
CHILD;
TUBERCULOSIS;
CHILD;
HUMANS;
TUBERCULOSIS;
|
EID: 34250306294
PISSN: 15260542
EISSN: 15260550
Source Type: Journal
DOI: 10.1016/j.prrv.2007.05.001 Document Type: Editorial |
Times cited : (3)
|
References (7)
|